Cite
MLA Citation
Rudolf Weide et al.. “Retreatment with bendamustine-containing regimens in patients with relapsed/refractory chronic lymphocytic leukemia and indolent B-cell lymphomas achieves high response rates and some long lasting remissions.” Leukemia & lymphoma, vol. 54, no. 8, n.d., pp. 1640–1646. http://access.bl.uk/ark:/81055/vdc_100024537312.0x000017